Login to Your Account



Financings Roundup

Replidyne Raises $62.5M; Health Care Remains Top Dog For VCs

By Karen Pihl-Carey


Friday, September 9, 2005
As its first product nears the market for respiratory infections, Replidyne Inc. brought in $62.5 million in a Series D round. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription